Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 11Other solid neoplasm 11Head & Neck 8Genitourinary 8Other hematologic neoplasm 7Gastrointestinal 6Lymphoid 5Gynecologic 5Breast 4Dermatologic 3CNS 2Tumor-Agnostic 1Sarcoma 1Plasma cell 1Other neoplasm 1Other 1Myeloid 1

Conditions

Hematopoietic and Lymphoid System Neoplasm 1

Interventions

Magnetic Resonance Spectroscopy 3Biopsy 3fludarabine 2Taxes 2Paclitaxel 2Endoscopic Mucosal Resection 2Aminolevulinic Acid 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2venetoclax 1trametinib 1toripalimab 1thymoglobulin 1taxane 1sintilimab 1potassium oxonate 1lutetium Lu 177 dotatate 1gimeracil 1fludarabine phosphate 1dabrafenib 1apatinib 1Whole-Body Irradiation 1Watchful Waiting 1Transurethral Resection of Prostate 1Tegafur 1Surgical Procedures, Operative 1Stem Cell Transplantation 1Standard of Care 1Specimen Handling 1Sirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Practice Guidelines as Topic × Other neoplasm × Clear all
NCT05772130 2026-01-05

Provider-Mediated Communication of Genetic Testing Results to At-Risk Relatives of Cancer Patients to Improve Genetic Counseling and Testing Rates, Family HOPE Study

City of Hope Medical Center

Phase NA Recruiting
240 enrolled
Other neoplasmOther solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡